Hims & Hers health COO Melissa Baird sells $3 million in stock

Published 14/02/2025, 22:54
Hims & Hers health COO Melissa Baird sells $3 million in stock

Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc. (NYSE:HIMS), has recently sold a significant portion of her holdings in the company. According to a recent SEC filing, Baird sold shares worth approximately $3,026,624 on February 12, 2025. The shares were sold at prices ranging from $43.37 to $46.27.

In addition to the sales, Baird exercised stock options to acquire 67,687 shares at an exercise price of $0.40 per share, totaling $27,074. Following these transactions, Baird holds 706,872 shares of Hims & Hers Health.

These transactions were conducted under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell stock at a future date, providing a defense against accusations of insider trading. For deeper insights into HIMS's valuation and 20 additional key investment tips, check out the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Hims Hers Health has been in the spotlight due to various developments. The company saw an uptick in demand for its weight loss products, as indicated by a 51% increase in year-to-date web traffic, according to Craig-Hallum analyst Alex Furhman. Despite facing criticism over a Super Bowl ad, Hims Hers Health defended its stance on providing affordable health care, which seems to have resonated with investors.

Meanwhile, BofA Securities maintained an underperform rating on the company due to potential challenges from pharmaceutical manufacturers. However, BTIG initiated coverage on Hims Hers Health with a buy rating, emphasizing its robust revenue growth and high demand for its products, particularly in the GLP-1 and obesity health product categories.

Furthermore, Needham & Company raised their price target on Hims Hers Health, positioning it as their top pick in the digital health sector for 2025. They highlighted the company's potential for growth and diverse strategy, which includes a focus on personalized product adoption and an expanding range of weight loss solutions. These developments underline the dynamic environment surrounding Hims Hers Health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.